Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: Systematic review and meta-analysis

Tropical Medicine and International Health

Volumn 20, Issue 12, 2015, Pages 1621-1633

  Chico, R Matthew ^a   Cano, Jorge ^a   Ariti, Cono ^a,b   Collier, Timothy J ^a   Chandramohan, Daniel ^a   Roper, Cally ^a   Greenwood, Brian ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b The Nuffield Trust   (United Kingdom)

Author keywords

Drug resistance; Malaria; Pregnancy; Sub Saharan; Sulphadoxine pyrimethamine; Transmission

Indexed keywords

DIHYDROPTEROATE SYNTHASE; PYRIMETHAMINE; SULFADOXINE; ANTIMALARIAL AGENT; DRUG COMBINATION; FANASIL, PYRIMETHAMINE DRUG COMBINATION;

ANTIBIOTICS; CONFIDENCE INTERVAL; DISEASE CONTROL; DISEASE INCIDENCE; DISEASE PREVALENCE; DISEASE RESISTANCE; DISEASE TRANSMISSION; DISEASE TREATMENT; EFFICIENCY MEASUREMENT; MALARIA; META-ANALYSIS; MUTATION; PARASITE; PREGNANCY; PROTOZOAN; SENSITIVITY ANALYSIS;

CODON; HUMAN; LOW BIRTH WEIGHT; MALARIA; META ANALYSIS; MULTIGRAVIDA; OBSERVATIONAL STUDY; PARASITEMIA; PREGNANCY; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; AFRICA SOUTH OF THE SAHARA; DRUG COMBINATION; DRUG RESISTANCE; FEMALE; GENETICS; MALARIA, FALCIPARUM; MUTATION; PARASITOLOGY; PLASMODIUM FALCIPARUM; PREGNANCY COMPLICATIONS, PARASITIC; TRANSMISSION;

SUB-SAHARAN AFRICA;

PLASMODIUM FALCIPARUM;

AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; GRAVIDITY; HUMANS; INFANT, LOW BIRTH WEIGHT; MALARIA, FALCIPARUM; MUTATION; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PYRIMETHAMINE; SULFADOXINE;

EID: 84955212361     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12595     Document Type: Review

References (51)

1. Wang P, Lee CS, Bayoumi R et al. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol Biochem Parasitol 1997: 89: 161-177.
2. Khan B, Omar S, Kanyara JN et al. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya. Trans R Soc Trop Med Hyg 1997: 91: 456-460.
3. Triglia T, Wang P, Sims PF, Hyde JE, Cowman AF. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. EMBO J 1998: 17: 3807-3815.
4. Kayentao K, Garner P, van Eijk AM, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA. 2013: 309: 594-604.
5. Gutman J, Kalilani L, Taylor S et al. The A581G mutation in the gene encoding Plasmodium falciparum dihydropteroate synthetase reduces the effectiveness of sulfadoxine-pyrimethamine preventive therapy in Malawian pregnant women. J Infect Dis 2015: 211: 1997-2005.
6. Committee WHOMPA, Secretariat. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting. Malar J 2013: 12: 456.
7. Brabin B. The Risks and Severity of Malaria in Pregnant Women. Applied Field Research in Malaria Reports. Special Programme for Research and Training in Tropical Diseases. World Health Organization: Geneva, 1991.
8. National Geospatial-Intelligence Agency. GEOnet Names Server. (Available from: http://earth-info.nga.mil/gns/html/namefiles.htm.), 2013.
9. ter Kuile FO, van Eijk AM, Filler SJ. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA 2007: 297: 2603-2616.
10. Consortium for Spatial Information. Washington, DC. (Available from: http://www.cgiar-csi.org.)
11. Balls MJ, Bodker R, Thomas CJ, Kisinza W, Msangeni HA, Lindsay SW. Effect of topography on the risk of malaria infection in the Usambara Mountains, Tanzania. Trans R Soc Trop Med Hyg 2004: 98: 400-408.
12. Walton GA. On the control of malaria in Freetown, Sierra Leone control methods and the effects upon the transmission of Plasmodium falciparum resulting from the reduced abundance of Anopheles gambiae. Ann Trop Med Parasitol 1949: 43: 117-139.
13. Brabin B. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983: 61: 1005-1016.
14. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987: 9: 1-30.
15. Berkey CS, Hoaglin DC, Mosteller F, Colditz GA. A random-effects regression model for meta-analysis. Stat Med 1995: 14: 395-411.
16. Naidoo I, Roper C. Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria. Trends Parasitol 2013: 29: 505-515.
17. Likwela JL, D'Alessandro U, Lokwa BL, Meuris S, Dramaix MW. Sulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC). Trop Med Int Health 2012: 17: 322-329.
18. Ndyomugyenyi R, Clarke SE, Hutchison CL, Hansen KS, Magnussen P. Efficacy of malaria prevention during pregnancy in an area of low and unstable transmission: an individually-randomised placebo-controlled trial using intermittent preventive treatment and insecticide-treated nets in the Kabale Highlands, southwestern Uganda. Trans R Soc Trop Med Hyg 2011: 105: 607-616.
19. Menendez C, Bardaji A, Sigauque B et al. A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS One 2008: 3: e1934.
20. Gies S, Coulibaly SO, Ouattara FT, D'Alessandro U. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight. Trop Med Int Health 2009: 14: 174-182.
21. Ramharter M, Schuster K, Bouyou-Akotet MK et al. Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon. Am J Trop Med Hyg 2007: 77: 418-422.
22. van Eijk AM, Ayisi JG, ter Kuile FO et al. Implementation of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in Kisumu, western Kenya. Trop Med Int Health 2004: 9: 630-637.
23. Sirima SB, Cotte AH, Konate A et al. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso. Am J Trop Med Hyg 2006: 75: 205-211.
24. Mbaye A, Richardson K, Balajo B et al. A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae. Trop Med Int Health 2006: 11: 992-1002.
25. Rogerson SJ, van den Broek NR, Chaluluka E, Qongwane C, Mhango CG, Molyneux ME. Malaria and anemia in antenatal women in Blantyre, Malawi: a twelve-month survey. Am J Trop Med Hyg 2000: 62: 335-340.
26. Mockenhaupt FP, Teun Bousema J, Eggelte TA et al. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana. Trop Med Int Health 2005: 10: 901-908.
27. Thera MA, Sehdev PS, Coulibaly D et al. Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. J Infect Dis 2005: 192: 1823-1829.
28. Ibrahim ML, Steenkeste N, Khim N et al. Field-based evidence of fast and global increase of Plasmodium falciparum drug-resistance by DNA-microarrays and PCR/RFLP in Niger. Malar J 2009: 8: 32.
29. Taylor SM, Antonia AL, Parobek CM et al. Plasmodium falciparum sulfadoxine resistance is geographically and genetically clustered within the DR Congo. Sci Rep 2013: 3: 1165.
30. Alker AP, Kazadi WM, Kutelemeni AK, Bloland PB, Tshefu AK, Meshnick SR. dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo. Trop Med Int Health 2008: 13: 1384-1391.
31. Lynch C, Pearce R, Pota H et al. Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda. J Infect Dis 2008: 197: 1598-1604.
32. Karema C, Imwong M, Fanello CI et al. Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria. Antimicrob Agents Chemother 2010: 54: 477-483.
33. Noranate N, Durand R, Tall A et al. Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One 2007: 2: e139.
34. Raman J, Sharp B, Kleinschmidt I et al. Differential effect of regional drug pressure on dihydrofolate reductase and dihydropteroate synthetase mutations in southern Mozambique. Am J Trop Med Hyg 2008: 78: 256-261.
35. Kun JF, Lehman LG, Lell B, Schmidt-Ott R, Kremsner PG. Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains. Antimicrob Agents Chemother 1999: 43: 2205-2208.
36. Aubouy A, Jafari S, Huart V et al. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy. J Antimicrob Chemother 2003: 52: 43-49.
37. Alker AP, Mwapasa V, Purfield A et al. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi. Antimicrob Agents Chemother 2005: 49: 3919-3921.
38. Bell DJ, Nyirongo SK, Mukaka M et al. Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi. PLoS One 2008: 3: e1578.
39. Omar SA, Adagu IS, Warhurst DC. Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure? Trans R Soc Trop Med Hyg 2001: 95: 315-319.
40. Zhong D, Afrane Y, Githeko A, Cui L, Menge DM, Yan G. Molecular epidemiology of drug-resistant malaria in western Kenya highlands. BMC Infect Dis 2008: 8: 105.
41. Harrington WE, Mutabingwa TK, Muehlenbachs A et al. Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci USA 2009: 106: 9027-9032.
42. Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE. Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis 2011: 53: 224-230.
43. Gesase S, Gosling RD, Hashim R et al. High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS One 2009: 4: e4569.
44. Schurmann D, Bergmann F, Albrecht H et al. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection. Eur J Clin Microbiol Infect Dis 2002: 21: 353-361.
45. Organization WH. Guidelines on Co-trimoxazole Prophylaxis for HIV-related Infections among Children, Adolescents and Adults. Recommendations for a Public Health Approach. World Health Organization: Geneva, Switzerland, 2006.
46. Bhattacharyya MN, Jones BM. Haemophilus vaginalis infection. Diagnosis and treatment. J Reprod Med 1980: 24: 71-75.
47. Chico RM, Hack BB, Newport MJ, Ngulube E, Chandramohan D. On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections. Expert Rev Anti Infect Ther 2013: 11: 1303-1332.
48. Chico RM, Mayaud P, Ariti C, Mabey D, Ronsmans C, Chandramohan D. Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa. JAMA 2012: 307: 2079-2086.
49. Naidoo I. Spatial and Temporal Analyses of Sulphadoxine Pyrimethamine Resistance in African Plasmodium falciparum malaria. London School of Hygiene & Tropical Medicine : University of London: London, 2015.
50. Spalding MD, Eyase FL, Akala HM et al. Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya. Malar J 2010: 9: 338.
51. Iriemenam NC, Shah M, Gatei W et al. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. Malar J 2012: 11: 134.